Silent and symptomatic primary carnitine deficiency within the same family due toidentical mutations in the organic cation/carnitine transporter OCTN2
- 1 September 2003
- journal article
- case report
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 26 (6), 613-615
- https://doi.org/10.1023/a:1025968502527
Abstract
A family of Turkish origin with primary systemic carnitine deficiency in the father and his two sons is described. In all three individuals, the same homozygous mutation in the OCTN2 gene (R471H) was present and carnitine uptake in fibroblasts was deficient. Whereas one boy became symptomatic with a Reye-syndrome-like picture of hepatopathy and encephalopathy in infancy, the other affected family members remained asymptomatic up to their current ages of 28 and 5 years, respectively.Keywords
This publication has 6 references indexed in Scilit:
- Novel OCTN2 mutations: No genotype–phenotype correlations: Early carnitine therapy prevents cardiomyopathyAmerican Journal of Medical Genetics, 2002
- Arginine 454 and Lysine 370 Are Essential for the Anion Specificity of the Organic Anion Transporter, rOAT3Biochemistry, 2001
- Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: Lack of genotype-phenotype correlationHuman Mutation, 2000
- Selectivity of the Polyspecific Cation Transporter rOCT1 Is Changed by Mutation of Aspartate 475 to GlutamateMolecular Pharmacology, 1999
- Genetic Epidemiology of the Carnitine Transporter OCTN2 Gene in a Japanese Population and Phenotypic Characterization in Japanese Pedigrees with Primary Systemic Carnitine DeficiencyHuman Molecular Genetics, 1999
- Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporterNature Genetics, 1999